Drug Research - Latest News & Updates on Drug Research

METiS TechBio and Eli Lilly Join Forces for Next-Generation Tissue-Specific LNP Delivery Technologies

Yuvraj — Wed, 21 Oct 2026 13:15:14 +0000

METiS TechBio has announced a strategic collaboration with Eli Lilly and Company to research and develop next-generation lipid nanoparticle (LNP)-based delivery solutions, leveraging METiS’s proprietary AI-driven platform to enable precise, tissue-specific delivery of therapeutic modalities. Under the terms of the agreement, METiS is eligible to receive an upfront payment in the low double-digit millions of […]

The post METiS TechBio and Eli Lilly Join Forces for Next-Generation Tissue-Specific LNP Delivery Technologies first appeared on World Pharma Today.

AstraZeneca Advances AI Drug Discovery Deal with insitro

Yuvraj — Fri, 16 Oct 2026 13:04:32 +0000

AstraZeneca has inked a billion-dollar AI drug discovery partnership and licensing deal with insitro to identify novel targets and therapies for a range of cardiometabolic diseases. Through this strategic agreement, the organizations will work in tandem to create drugs that fulfil unmet needs and address the underlying drivers of disease in both metabolic dysfunction-associated steatohepatitis […]

The post AstraZeneca Advances AI Drug Discovery Deal with insitro first appeared on World Pharma Today.

Identifying Sex Specific Outcomes Through Real-World Data Analysis

Yuvraj — Mon, 12 Oct 2026 12:04:01 +0000

The pharmaceutical sector is increasingly turning to large-scale datasets to understand how medications perform beyond the controlled environment of clinical trials. While traditional research provides a foundation for drug approval, the actual impact of a therapy can only be fully understood through real-world data analysis. This analytical approach allows researchers to observe how diverse patient […]

The post Identifying Sex Specific Outcomes Through Real-World Data Analysis first appeared on World Pharma Today.

Strengthening Clinical Evidence Through Female Cohort Representation

Yuvraj — Mon, 12 Oct 2026 11:55:51 +0000

The pharmaceutical industry is undergoing a fundamental shift in how it approaches patient diversity within clinical research. For decades, clinical trials often under-represented women, leading to gaps in knowledge regarding drug safety and efficacy for a significant portion of the population. Today, the focus on female cohort representation is recognized as a critical component of […]

The post Strengthening Clinical Evidence Through Female Cohort Representation first appeared on World Pharma Today.

Advancing Menopause Treatments Through Hormonal Pathway Research

Yuvraj — Mon, 12 Oct 2026 11:47:25 +0000

The pharmaceutical sector is witnessing a renewed focus on the complex biological changes associated with the transition into menopause. Central to this evolution is the depth of hormonal pathway research, which provides the foundation for developing more effective and personalized therapies. For decades, menopause was treated with a generalized approach, often overlooking the intricate variations […]

The post Advancing Menopause Treatments Through Hormonal Pathway Research first appeared on World Pharma Today.

Enhancing Drug Success with Female Cardiovascular Biomarkers

Yuvraj — Sat, 10 Oct 2026 08:46:12 +0000

Cardiovascular disease remains a leading cause of mortality among women, yet the mechanisms of disease progression often differ significantly from those observed in men. For many years, the pharmaceutical industry relied on generalized markers of heart health, which occasionally led to a lack of sensitivity in detecting early-stage issues in female patients. The emergence of […]

The post Enhancing Drug Success with Female Cardiovascular Biomarkers first appeared on World Pharma Today.

Optimizing Autoimmune Selection with Female Immune Biomarkers

Yuvraj — Sat, 10 Oct 2026 08:36:13 +0000

Autoimmune diseases affect women at a disproportionately high rate, with nearly 80 percent of all patients being female. Despite this staggering statistic, the underlying biological reasons for this disparity are only recently being understood with the necessary scientific depth. The pharmaceutical industry is now pivoting toward the identification of female immune biomarkers to improve how […]

The post Optimizing Autoimmune Selection with Female Immune Biomarkers first appeared on World Pharma Today.

Dr. Thomas Megerian on Autism, Hope, and the Long Road to Approval

Yuvraj — Wed, 30 Sep 2026 05:28:40 +0000

World Pharma Today recently spoke with Dr. Thomas Megerian, a physician who has spent three decades in neurodevelopmental medicine. He serves as Clinical Director of the Thompson Autism and Developmental Center at the Children’s Hospital of Orange County and as Chief of the Division of Neurodevelopmental Medicine. In this exclusive feature, Dr. Megerian discusses L-179, […]

The post Dr. Thomas Megerian on Autism, Hope, and the Long Road to Approval first appeared on World Pharma Today.

Roche and Earendil Forge $1.5 Billion Bispecific Antibody Discovery Deal

Yuvraj — Sat, 26 Sep 2026 04:50:59 +0000

Roche-owned Genentech has entered into a major collaboration with Earendil Labs to discover and develop bispecific antibodies targeting oncology, in a deal valued at up to $1.5 billion. Deal Structure and Financial Terms Under the terms of the agreement, Earendil will receive $55 million upfront, along with up to $1.445 billion in development, regulatory, and […]

The post Roche and Earendil Forge $1.5 Billion Bispecific Antibody Discovery Deal first appeared on World Pharma Today.

AbbVie and Iambic Partner to Accelerate AI Drug Discovery in Immunology, Neuroscience and Oncology

Yuvraj — Fri, 25 Sep 2026 13:37:17 +0000

AbbVie and Iambic have entered into a multiyear collaboration focused on AI drug discovery across three major therapeutic areas — immunology, neuroscience, and oncology. The partnership brings together Iambic’s molecular superintelligence platform and AbbVie’s established drug discovery expertise, with the shared goal of identifying and developing small molecule therapies with first-in-class and best-in-class potential. Financial […]

The post AbbVie and Iambic Partner to Accelerate AI Drug Discovery in Immunology, Neuroscience and Oncology first appeared on World Pharma Today.